Статья

GWAS and polygenic risk score of severe COVID-19 in Eastern Europe

Kovalenko, Elena, Shaheen, Layal, Vergasova, Ekaterina, Kamelin, Alexey, Rubinova, Valerya, Kharitonov, Dmitry, Kim, Anna, Plotnikov, Nikolay, Elmuratov, Artem, Borovkova, Natalia, Storozheva, Maya, Solonin, Sergey, Gilyazova, Irina, Mironov, Petr, Khusnutdinova, Elza, Petrikov, Sergey, Ilinskaya, Anna, Ilinsky, Valery, Rakitko, Alexander
2024

Background: COVID-19 disease has infected more than 772 million people, leading to 7 million deaths. Although the severe course of COVID-19 can be prevented using appropriate treatments, effective interventions require a thorough research of the genetic factors involved in its pathogenesis. Methods: We conducted a genome-wide association study (GWAS) on 7,124 individuals (comprising 6,400 controls who had mild to moderate COVID-19 and 724 cases with severe COVID-19). The inclusion criteria were acute respiratory distress syndrome (ARDS), acute respiratory failure (ARF) requiring respiratory support, or CT scans indicative of severe COVID-19 infection without any competing diseases. We also developed a polygenic risk score (PRS) model to identify individuals at high risk. Results: We identified two genome-wide significant loci (P-value

Цитирование

Похожие публикации